Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab

Bibliographic Details
Main Authors: Postow, Michael A, Cardona, Diana M, Taube, Janis M, Anders, Robert A, Taylor, Clive R, Wolchok, Jedd D, Callahan, Margaret K, Curran, Michael A, Lesokhin, Alexander M, Grosso, Joseph F, Horak, Christine E, Cogswell, John, Simon, Jason S, Gupta, Ashok K, Sznol, Mario
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108855/
id pubmed-4108855
recordtype oai_dc
spelling pubmed-41088552014-08-04 Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab Postow, Michael A Cardona, Diana M Taube, Janis M Anders, Robert A Taylor, Clive R Wolchok, Jedd D Callahan, Margaret K Curran, Michael A Lesokhin, Alexander M Grosso, Joseph F Horak, Christine E Cogswell, John Simon, Jason S Gupta, Ashok K Sznol, Mario Oral Presentation BioMed Central 2014-05-06 /pmc/articles/PMC4108855/ http://dx.doi.org/10.1186/1479-5876-12-S1-O8 Text en Copyright © 2014 Postow et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Postow, Michael A
Cardona, Diana M
Taube, Janis M
Anders, Robert A
Taylor, Clive R
Wolchok, Jedd D
Callahan, Margaret K
Curran, Michael A
Lesokhin, Alexander M
Grosso, Joseph F
Horak, Christine E
Cogswell, John
Simon, Jason S
Gupta, Ashok K
Sznol, Mario
spellingShingle Postow, Michael A
Cardona, Diana M
Taube, Janis M
Anders, Robert A
Taylor, Clive R
Wolchok, Jedd D
Callahan, Margaret K
Curran, Michael A
Lesokhin, Alexander M
Grosso, Joseph F
Horak, Christine E
Cogswell, John
Simon, Jason S
Gupta, Ashok K
Sznol, Mario
Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
author_facet Postow, Michael A
Cardona, Diana M
Taube, Janis M
Anders, Robert A
Taylor, Clive R
Wolchok, Jedd D
Callahan, Margaret K
Curran, Michael A
Lesokhin, Alexander M
Grosso, Joseph F
Horak, Christine E
Cogswell, John
Simon, Jason S
Gupta, Ashok K
Sznol, Mario
author_sort Postow, Michael A
title Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
title_short Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
title_full Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
title_fullStr Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
title_full_unstemmed Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
title_sort peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-pd-1, bms-936558, ono-4538) monotherapy or in combination with ipilimumab
description
publisher BioMed Central
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108855/
_version_ 1613117281285439488

Similar Items